$125.35-1.38% today
- 5Y
- +42.71%
- $10K became
- $14,271
ORCL vs SPY
Total return with dividends reinvested · 5Y
ORCL
SPY
$754.37-0.36% today
- 5Y
- +72.62%
- $10K became
- $17,262
Return and risk 5Y
| Ticker | $10K became | Total | Per year | Volatility | Worst drop | Off high now | Best year | Worst year | Years up | Corr. with ORCL |
|---|---|---|---|---|---|---|---|---|---|---|
| ORCL | $14,271 | +42.71% | +7.38% | 45.3% | -64.58% | -61.25% | +62.10% 2024 | -5.39% 2022 | 75% | — |
| SPY | $17,262 | +72.62% | +11.55% | 17.3% | -24.49% | -3.17% | +26.73% 2023 | -18.64% 2022 | 75% | 0.48 |
ORCL
- $10K became
- $14,271
- Total
- +42.71%
- Per year
- +7.38%
- Volatility
- 45.3%
- Worst drop
- -64.58%
- Off high now
- -61.25%
- Best year
- +62.10% 2024
- Worst year
- -5.39% 2022
SPY
- $10K became
- $17,262
- Total
- +72.62%
- Per year
- +11.55%
- Volatility
- 17.3%
- Worst drop
- -24.49%
- Off high now
- -3.17%
- Best year
- +26.73% 2023
- Worst year
- -18.64% 2022
Per year: compound annual growth rate, needs a year of history. Volatility: yearly spread of daily returns. Best and worst years: full calendar years only.
Drawdown from peak 5Y
0%-35%-70%
2021-112026-11
Correlation of daily returns
ORCLSPYORCL1.000.48SPY0.481.00
1 moves together, 0 unrelated, negative moves opposite. Lower means more diversification.
Trailing returns up to 5 years
| Ticker | 1Y | 2Y | 3Y | 5Y |
|---|---|---|---|---|
| ORCL | — | — | — | — |
| SPY | — | — | — | — |
Calendar-year returns best each year in bold
| Year | ORCL | SPY |
|---|---|---|
| No full years in this range yet. | ||
More comparisons
About this comparison
Summary, desk note and 6 common questions.
Oracle Corporation (ORCL) vs State Street SPDR S&P 500 ETF Trust (SPY) total return over 5Y: ORCL +42.71%, SPY +72.62%. As of Nov 13, 2026. Research only.
Oracle Corp. (ORCL) closed at $127.1 on 2026‑11‑12, while the S&P 500 ETF (SPY) ended the session at $757.1. Over the past five years the total‑return overlay—dividends and splits—has lifted ORCL by +44.7% versus a +73.2% gain for SPY, underscoring the broader market’s outperformance despite Oracle’s solid cloud‑driven revenue growth and a 1.57% dividend yield. The Oracle signal reads SELL with a modest composite score of –10.90; the stock sits in a “RECOVERY” market regime and is classified as a Dividend Compounder (blended). Its valuation metrics (P/E TTM 19.5, ROE 42.6%) reflect a high‑quality tech name, but elevated capex and margin pressure temper the outlook. Open the Oracle page for full overlay methodology. SPY’s overlay also shows a SELL signal, now in a “BEAR” regime, and is tagged as a Balanced archetype. The ETF’s quality score of 53.6 and its broad market exposure keep it a benchmark reference. View the SPY page for complete overlay details.
What does the ORCL vs SPY overlay show?
LOPJLB overlays ORCL vs SPY as total return (dividends and splits) from the first adjusted close in the selected 5Y window. Each path starts at 0% so you can read relative holding performance, not raw tape price.
Is this holding return or tape close?
Holding return. The series uses split- and dividend-adjusted close (Yahoo-style backward adjustment) when dividend coverage is sufficient, otherwise it falls back to tape close. Candles and technical overlays on /chart stay tape.
Which windows are public?
Public visitors can share 1M, 3M, 6M, YTD, 1Y, and 5Y. MAX is Research+. Direction and regime in the table follow the desk ladder: SPY25 on Free, full book on Essential+.
How do I read the drawdown, period, and annual tables?
Drawdowns are current and worst peak-to-trough on the visible range. Periods are calendar lookbacks (1Y / 2Y / 3Y / 5Y, plus 10Y on MAX) from the last bar. Annual is calendar-year holding return, with the latest year labeled YTD.
How has ORCL vs SPY performed on a normalized basis?
ORCL vs SPY holding-return overlay: 5Y ORCL +42.71% · SPY +72.62%; worst drawdown ORCL -64.58% · SPY -24.49%; YTD ORCL -35.10% · SPY +11.29%. Numbers update from the live compare-series book.
Is ticker compare investment advice?
No. The overlay is research context only — not a recommendation to buy or sell any security.